ACC 2016: Statin helps prevent cardiovascular events in intermediate-risk group
by Bruce Sylvester: Rosuvastatin treatment more effectively prevents cardiovascular events than candesartan plus hydrochlorothiazide among subjects who do not have cardiovascular disease and who received cholesterol-lowering treatment.